S U M MARY A quantitative electro-oculographic method was used to assess the impairment in smooth-pursuit and vestibulo-ocular reflex suppression eye movements in 12 epileptic patients and eight normal volunteers. Both types of eye movement were impaired by a factor of 40% in the epileptic patients, and the impairment was at least partly due to the treatment with phenytoin and phenobarbitone. There was a strong positive correlation between the performances in vestibulo-ocular reflex suppression and smooth-pursuit.
Among the more prominent signs of acute antiepileptic drug toxicity are those of vestibulocerebellar origin, such as nystagmus, ataxia and dysarthria. Less commonly reported, perhaps because they are more subtle, are slowness of thought, asterixis and behavioural changes.1 2 Impairment of brain function in patients who do not show evident signs of acute antiepileptic drug toxicity, and whose serum antiepileptic drug concentrations are within the so-called therapeutic ranges,3 is more difficult to measure, but needs to be assessed in determining the long-term effects of the treatment, as well as of the seizure disorder itself. In this study we have establighed simple and reliable electro-oculographic criteria to indicate the degree of impairment in oculomotor function in drug-treated epileptic patients who do not show evident signs of acute antiepileptic drug toxicity.
All eye movements except microtremor either switch gaze from one target to the next, or maintain gaze when either the target or the patient's head is moving. Saccades are the fast movements used to transfer the fixation point between various targets. Their peak velocity may reach 7000 /S,4 and vision is not optimum during the saccade itself. 5The vestibulo-ocular reflex (VOR) is used to maintain gaze on stationary targets while the head is moving. It generates eye movements of equal speed but opposite direction to the head movement, such that head and eye displacements cancel each other and the direction of visual fixation remains undisturbed.6 Smooth-pursuit eye movements are used to track targets moving in the external world when the head is immobile. Should a person try to track a moving object using both head and eyes, the VOR and the pursuit system come into conflict. As the head moves in the direction of the target, the VOR drives the eyes in the opposite direction, while the pursuit system is trying to drive the eyes along with the target.7 The VOR then, has to be overcome, so that the added head and eye velocity can equal that of the moving target. The mechanism by which the VOR is overcome is referred to as VOR suppression. There is much evidence that an alternative role for the pursuit system is VOR suppression.7-9 An important finding ils that there are limits to the velocity of both smooth-pursuit and VOR suppression. When the head is immobile, the pursuit system can track moving targets up to a certain threshold velocity, above which saccades have to be used to catch up with the target. If the head is moving, head velocity may exceed the capacity of the pursuit system, so that complete supression is impossible. It has been suggested that when pursuit reaches its threshold velocity, so does VOR suppression.7-9 Depending on experimental conditions, the pursuit threshold velocity in the human has been given as between 40-800/s. 9 fig 2) are used to bring the eyes quickly on to the target. These saccades also increase in size as chair velocity (in phase with head and target) increases. In some cases, the VOR itself is not suppressed, and may underlie the nystagmus-like trace (fig 2) , but in all cases the nystagmus was the first manifestation of failure of suppression.
We defined the "pursuit threshold velocity" as that peak angular velocity of target motion at which saccades larger than 50 appeared consistently on the electro-oculogram. The "VOR suppression threshold velocity" was defined as the peak angular velocity of chair (head) motion at which 20 saccades were consistently present on the electro-oculogram. The development of these criteria took into account the biological and electrogenic noise levels in our recordings, as well as the facility with which the naked eye can see these saccades. During smooth-pursuit, saccades larger than 150 in amplitude, or those not in the direction of the target were not taken into account, since they usually demonstrated lack of attention, as described in psychiatric populations. '1 12 Quantitative assessment of smooth-pursuit eye mnovements in healthy and epileptic subjects n <\ ; r AJXJ*\~-4- 
Results
The mean number of antiepileptic drugs per patient was 1-75. Figure 3 shows the range of phenytoin, phenobarbitone and carbamazepine levels observed during the study. Three of the patients had "toxic" serum concentrations of phenytoin, and one of phenobarbitone, when first tested. In all four patients t'he levels returned to the "therapeutic" range as the study progressed. In one patient phenytoin was withdrawn, and, in another, primidone. Both remained on carbamazepine. The six other patients had serum levels that never exceeded the upper limits of the therapeutic range, and none had drugs withdrawn during the study.
VOR was not impaired in any of the subjects, both the amplitude and morphology of the eye 
